CAVADEXA 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, PVC/PVdC-Alu blister pack

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

lamivudine, Quantity: 300 mg; abacavir sulfate, Quantity: 702.762 mg (Equivalent: abacavir, Qty 600 mg)

Prieinama:

Hetero Australia Pty Ltd

Vaisto forma:

Tablet

Sudėtis:

Excipient Ingredients: sodium starch glycollate; colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate; titanium dioxide; hypromellose; sunset yellow FCF; polysorbate 80; macrogol 400

Vartojimo būdas:

Oral

Vienetai pakuotėje:

30's

Recepto tipas:

(S4) Prescription Only Medicine

Terapinės indikacijos:

CAVADEXA 600/300 tablets are a combinaton of two nucleoside analogues (abacavir and lamivudine). CAVADEXA 600/300 is indicated in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infection in adults and adolescents from 12 years of age.

Produkto santrauka:

Visual Identification: Orange modified capsule shaped, biconvex film-coated tablets debossed with 'H' on one side and 'A1' on other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Autorizacija statusas:

Registered

Leidimo data:

2022-12-13

Pakuotės lapelis

CAVADEXA 600/300/07112018/V2
1
CAVADEXA 600/300 TABLETS
_abacavir (as sulfate) and lamivudine_
CONSUMER MEDICINE INFORMATION
PATIENTS TAKING CAVADEXA 600/300, WHICH CONTAINS ABACAVIR, MAY DEVELOP
A
HYPERSENSITIVITY
REACTION (SERIOUS ALLERGIC REACTION) WHICH CAN BE LIFE-THREATENING IF
TREATMENT
WITH CAVADEXA 600/300 IS CONTINUED. CONTACT YOUR DOCTOR IMMEDIATELY
FOR ADVICE ON
WHETHER YOU SHOULD STOP TAKING CAVADEXA 600/300 IF:
1)
YOU GET A SKIN RASH OR
2)
YOU GET ONE OR MORE SYMPTOMS FROM AT LEAST TWO OF THE FOLLOWING
GROUPS:
-
FEVER
-
SHORTNESS OF BREATH, SORE THROAT OR COUGH
-
NAUSEA OR VOMITING OR DIARRHOEA OR ABDOMINAL PAIN
-
SEVERE TIREDNESS OR ACHINESS OR GENERALLY ILL FEELING
IF YOU HAVE HAD A HYPERSENSITIVITY (ALLERGIC) REACTION TO CAVADEXA
600/300 TABLETS,
NEVER TAKE
CAVADEXA 600/300, OR ANY OTHER MEDICINAL PRODUCT CONTAINING ABACAVIR
(KIVEXA,
TRIUMEQ, TRIZIVIR &
ZIAGEN) AGAIN AS YOU MAY DEVELOP A LIFE THREATENING REACTION WHICH CAN
BE FATAL.
THERE IS AN ALERT CARD INCLUDED IN THE CAVADEXA 600/300 PACK, TO
REMIND YOU AND
MEDICAL STAFF ABOUT ABACAVIR HYPERSENSITIVITY. THIS CARD SHOULD BE
REMOVED FROM
THE PACK AND KEPT WITH YOU AT ALL TIMES. SEE MORE DETAILS UNDER BEFORE
YOU TAKE
CAVADEXA 600/300.
CAVADEXA 600/300/07112018/V2
2
WHAT IS IN THIS LEAFLET?
Please read this leaflet carefully
before you start CAVADEXA
600/300 tablets.
This leaflet answers some common
questions about CAVADEXA
600/300 tablets. It does not contain
all of the available information.
It does not take the place of talking
to your doctor or pharmacist (also
known as a chemist).
All medicines have benefits and
risks. Your doctor has weighed the
expected benefits of you taking
CAVADEXA 600/300 tablets
against the risks this medicine could
have for you.
IF YOU HAVE ANY CONCERNS ABOUT
TAKING THIS MEDICINE, ASK YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET WITH THE TABLETS.
You may need to read it again.
WHAT CAVADEXA
600/300 TABLETS ARE
USED FOR
CAVADEXA 600/300 tablets
contain abacavir and lamivudine
which belong to a group of
medicines calle